Are New Alzheimer Drugs Better Than Older Drugs?
Susan Molchan, Adriane Fugh‐Berman
Abstract
This Viewpoint explores whether there are benefits to drugs targeting β-amyloid protein in treating Alzheimer disease.
Topics & Concepts
MedicineAlzheimer's diseaseDrugIntensive care medicinePharmacologyInternal medicineDiseaseAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases